INVA logo

Innoviva (INVA) EBITDA

Annual EBITDA

$235.04 M
-$73.28 M-23.77%

December 31, 2023

Summary

Performance

1-Year Change

-23.77%

3-Year Change

-39.17%

5-Year Change

-5.26%

15-Year Change

+22.51%

INVA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.46%
INVA annual EBITDA is higher than 89.46% of companies in Healthcare sector

High & Low

All-time High

$464.35 M
INVA annual EBITDA is currently -49.38% below its historical high of $464.35 million

3-Year Low

$235.04 M
INVA annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
INVA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
INVA next annual earnings announcement is scheduled for Feb 28, 2025

OtherINVAprofitabilitymetrics:

Annual Revenue

$310.46 M
INVA annual revenue is $310.46 million

Annual Net Income

$179.72 M
INVA annual net profit is $179.72 million

Annual EBIT

$213.25 M
INVA annual earnings before interest & taxes is $213.25 million

Annual EPS

$2.20
INVA annual earnings per share is $2.20

Quarterly EBITDA

$19.17 M
+$46.20 M+170.89%

September 1, 2024

Summary

Performance

3-Month Change

+170.89%

1-Year Change

-80.21%

3-Year Change

-68.75%

5-Year Change

-70.79%

INVA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.32%
INVA quarterly EBITDA is higher than 84.32% of companies in Healthcare sector

High & Low

All-time High

$293.03 M
INVA quarterly EBITDA is currently -93.46% below its historical high of $293.03 million

3-Year Low

-$56.59 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
INVA previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
INVA next earnings announcement is scheduled for Feb 28, 2025

OtherINVAprofitabilitymetrics:

Quarterly Revenue

$89.51 M
INVA quarterly revenue is $89.51 million

Quarterly Net Income

$1.21 M
INVA quarterly net profit is $1.21 million

Quarterly EBIT

$12.66 M
INVA quarterly earnings before interest & taxes is $12.66 million

Quarterly EPS

$0.02
INVA quarterly earnings per share is $0.02

TTM EBITDA

$123.21 M
-$77.69 M-38.67%

September 1, 2024

Summary

Performance

3-Month Change

-38.67%

1-Year Change

+17.58%

3-Year Change

-74.05%

5-Year Change

-60.46%

INVA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.12%
INVA TTM EBITDA is higher than 87.12% of companies in Healthcare sector

High & Low

All-time High

$508.80 M
INVA TTM EBITDA is currently -75.78% below its historical high of $508.80 million

3-Year Low

$104.79 M
INVA TTM EBITDA is currently +17.58% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
INVA previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
INVA next earnings announcement is scheduled for Feb 28, 2025

OtherINVAprofitabilitymetrics:

TTM Revenue

$352.75 M
INVA TTM revenue is $352.75 million

TTM Net Income

$64.59 M
INVA TTM net profit is $64.59 million

TTM EBIT

$97.31 M
INVA TTM earnings before interest & taxes is $97.31 million

TTM EPS

$0.69
INVA TTM earnings per share is $0.69

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$235.04 M
INVA annual EBITDA is $235.04 million

Annual Net Income

$179.72 M
INVA annual net profit is $179.72 million

Annual Interest Expense

$19.16 M
INVA annual interest expense is $19.16 million

Annual Income Tax

$14.38 M
INVA annual income tax is $14.38 million

Annual D&A

$21.78 M
INVA annual depreciation & amortization is $21.78 million

INVA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-23.8%-80.2%+17.6%
3 y3 years-39.2%-68.8%-74.0%
5 y5 years-5.3%-70.8%-60.5%

INVA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-49.4%at low-93.5%+133.9%-74.0%+17.6%
5 y5-year-49.4%at low-93.5%+133.9%-75.8%+17.6%
alltimeall time-49.4%+234.3%-93.5%+133.9%-75.8%+168.9%

Innoviva EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$19.17 M(-170.9%)
$123.21 M(-38.7%)
Jun 2024
-
-$27.04 M(-147.1%)
$200.90 M(-17.4%)
Mar 2024
-
$57.41 M(-22.1%)
$243.08 M(+3.4%)
Dec 2023
$235.04 M(-23.8%)
$73.66 M(-23.9%)
$235.04 M(+124.3%)
Sep 2023
-
$96.86 M(+539.5%)
$104.79 M(-65.2%)
Jun 2023
-
$15.14 M(-69.3%)
$300.96 M(-2.9%)
Mar 2023
-
$49.37 M(-187.2%)
$309.96 M(+0.5%)
Dec 2022
$308.32 M(-33.6%)
-$56.59 M(-119.3%)
$308.32 M(-27.7%)
Sep 2022
-
$293.03 M(+1113.4%)
$426.24 M(+61.1%)
Jun 2022
-
$24.15 M(-49.4%)
$264.63 M(-31.2%)
Mar 2022
-
$47.73 M(-22.2%)
$384.87 M(-18.9%)
Dec 2021
$464.35 M(+20.2%)
$61.33 M(-53.3%)
$474.72 M(-6.7%)
Sep 2021
-
$131.43 M(-9.0%)
$508.80 M(+16.7%)
Jun 2021
-
$144.38 M(+4.9%)
$435.93 M(+4.4%)
Mar 2021
-
$137.59 M(+44.2%)
$417.68 M(+9.1%)
Dec 2020
$386.42 M(+45.6%)
$95.41 M(+63.0%)
$382.96 M(+4.6%)
Sep 2020
-
$58.55 M(-53.6%)
$365.98 M(-1.9%)
Jun 2020
-
$126.14 M(+22.6%)
$373.05 M(+19.7%)
Mar 2020
-
$102.86 M(+31.2%)
$311.61 M(+17.4%)
Dec 2019
$265.43 M(+7.0%)
$78.43 M(+19.5%)
$265.43 M(-1.0%)
Sep 2019
-
$65.62 M(+1.4%)
$268.19 M(+2.6%)
Jun 2019
-
$64.70 M(+14.1%)
$261.44 M(-0.7%)
Mar 2019
-
$56.68 M(-30.2%)
$263.31 M(+6.1%)
Dec 2018
$248.08 M(+29.3%)
$81.19 M(+37.9%)
$248.08 M(+4.6%)
Sep 2018
-
$58.87 M(-11.6%)
$237.26 M(+9.9%)
Jun 2018
-
$66.56 M(+60.6%)
$215.91 M(+7.9%)
Mar 2018
-
$41.45 M(-41.1%)
$200.19 M(+4.3%)
Dec 2017
$191.86 M(+52.3%)
$70.37 M(+87.5%)
$191.86 M(+17.3%)
Sep 2017
-
$37.52 M(-26.2%)
$163.55 M(+3.7%)
Jun 2017
-
$50.84 M(+53.5%)
$157.66 M(+14.2%)
Mar 2017
-
$33.12 M(-21.3%)
$138.05 M(+9.6%)
Dec 2016
$126.00 M(+168.2%)
$42.06 M(+33.0%)
$126.00 M(+20.3%)
Sep 2016
-
$31.63 M(+1.2%)
$104.77 M(+23.1%)
Jun 2016
-
$31.24 M(+48.2%)
$85.11 M(+36.1%)
Mar 2016
-
$21.07 M(+1.2%)
$62.53 M(+33.1%)
Dec 2015
$46.98 M(-292.0%)
$20.83 M(+74.2%)
$46.98 M(+79.0%)
Sep 2015
-
$11.96 M(+38.1%)
$26.24 M(+244.7%)
Jun 2015
-
$8.66 M(+56.8%)
$7.61 M(-208.1%)
Mar 2015
-
$5.52 M(+5712.6%)
-$7.04 M(-71.2%)
Dec 2014
-$24.46 M(+37.2%)
$95.00 K(-101.4%)
-$24.46 M(-19.2%)
Sep 2014
-
-$6.66 M(+11.2%)
-$30.27 M(-2.9%)
Jun 2014
-
-$5.99 M(-49.6%)
-$31.16 M(+32.4%)
Mar 2014
-
-$11.90 M(+108.4%)
-$23.54 M(-46.9%)
DateAnnualQuarterlyTTM
Dec 2013
-$17.83 M(-16.8%)
-$5.71 M(-24.4%)
-$44.37 M(-45.0%)
Sep 2013
-
-$7.55 M(-565.6%)
-$80.63 M(-22.8%)
Jun 2013
-
$1.62 M(-105.0%)
-$104.38 M(-25.4%)
Mar 2013
-
-$32.73 M(-22.0%)
-$139.96 M(+628.0%)
Dec 2012
-$21.43 M(-78.9%)
-$41.97 M(+34.1%)
-$19.22 M(+80.8%)
Sep 2012
-
-$31.30 M(-7.8%)
-$10.63 M(+66.1%)
Jun 2012
-
-$33.96 M(-138.6%)
-$6.40 M(-210.8%)
Mar 2012
-
$88.01 M(-363.6%)
$5.78 M(-105.7%)
Dec 2011
-$101.74 M(+42.3%)
-$33.38 M(+23.3%)
-$101.74 M(+20.4%)
Sep 2011
-
-$27.07 M(+24.3%)
-$84.51 M(+11.8%)
Jun 2011
-
-$21.78 M(+11.7%)
-$75.59 M(+5.7%)
Mar 2011
-
-$19.51 M(+20.8%)
-$71.48 M(+0.0%)
Dec 2010
-$71.48 M(-4.3%)
-$16.15 M(-11.0%)
-$71.48 M(-4.1%)
Sep 2010
-
-$18.15 M(+2.7%)
-$74.56 M(-1.9%)
Jun 2010
-
-$17.68 M(-9.4%)
-$76.00 M(-3.0%)
Mar 2010
-
-$19.50 M(+1.4%)
-$78.32 M(+4.9%)
Dec 2009
-$74.67 M(-7.6%)
-$19.23 M(-1.9%)
-$74.67 M(+7.6%)
Sep 2009
-
-$19.59 M(-2.0%)
-$69.40 M(+0.9%)
Jun 2009
-
-$20.00 M(+26.1%)
-$68.79 M(+0.8%)
Mar 2009
-
-$15.86 M(+13.7%)
-$68.22 M(-15.6%)
Dec 2008
-$80.82 M(-50.9%)
-$13.95 M(-26.5%)
-$80.82 M(-18.5%)
Sep 2008
-
-$18.98 M(-2.3%)
-$99.19 M(-13.1%)
Jun 2008
-
-$19.43 M(-31.7%)
-$114.13 M(-19.4%)
Mar 2008
-
-$28.46 M(-11.9%)
-$141.58 M(-13.9%)
Dec 2007
-$164.51 M(-6.0%)
-$32.31 M(-4.7%)
-$164.51 M(-4.5%)
Sep 2007
-
-$33.92 M(-27.6%)
-$172.31 M(-3.6%)
Jun 2007
-
-$46.88 M(-8.8%)
-$178.78 M(+1.8%)
Mar 2007
-
-$51.39 M(+28.1%)
-$175.57 M(+0.3%)
Dec 2006
-$174.97 M(+20.3%)
-$40.11 M(-0.7%)
-$174.97 M(-1.6%)
Sep 2006
-
-$40.40 M(-7.5%)
-$177.75 M(+1.2%)
Jun 2006
-
-$43.67 M(-14.0%)
-$175.70 M(+7.0%)
Mar 2006
-
-$50.79 M(+18.4%)
-$164.25 M(+12.9%)
Dec 2005
-$145.45 M(+47.5%)
-$42.90 M(+11.9%)
-$145.45 M(+12.6%)
Sep 2005
-
-$38.34 M(+19.0%)
-$129.15 M(+14.4%)
Jun 2005
-
-$32.22 M(+0.7%)
-$112.93 M(+1.0%)
Mar 2005
-
-$31.99 M(+20.3%)
-$111.84 M(+40.1%)
Dec 2004
-$98.58 M(+46.6%)
-$26.60 M(+20.2%)
-$79.85 M(+49.9%)
Sep 2004
-
-$22.13 M(-28.9%)
-$53.26 M(+71.1%)
Jun 2004
-
-$31.13 M
-$31.13 M
Dec 2003
-$67.26 M(-13.7%)
-
-
Dec 2002
-$77.96 M(+45.0%)
-
-
Dec 2001
-$53.77 M(-48.3%)
-
-
Dec 2000
-$103.93 M
-
-

FAQ

  • What is Innoviva annual EBITDA?
  • What is the all time high annual EBITDA for Innoviva?
  • What is Innoviva annual EBITDA year-on-year change?
  • What is Innoviva quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Innoviva?
  • What is Innoviva quarterly EBITDA year-on-year change?
  • What is Innoviva TTM EBITDA?
  • What is the all time high TTM EBITDA for Innoviva?
  • What is Innoviva TTM EBITDA year-on-year change?

What is Innoviva annual EBITDA?

The current annual EBITDA of INVA is $235.04 M

What is the all time high annual EBITDA for Innoviva?

Innoviva all-time high annual EBITDA is $464.35 M

What is Innoviva annual EBITDA year-on-year change?

Over the past year, INVA annual EBITDA has changed by -$73.28 M (-23.77%)

What is Innoviva quarterly EBITDA?

The current quarterly EBITDA of INVA is $19.17 M

What is the all time high quarterly EBITDA for Innoviva?

Innoviva all-time high quarterly EBITDA is $293.03 M

What is Innoviva quarterly EBITDA year-on-year change?

Over the past year, INVA quarterly EBITDA has changed by -$77.69 M (-80.21%)

What is Innoviva TTM EBITDA?

The current TTM EBITDA of INVA is $123.21 M

What is the all time high TTM EBITDA for Innoviva?

Innoviva all-time high TTM EBITDA is $508.80 M

What is Innoviva TTM EBITDA year-on-year change?

Over the past year, INVA TTM EBITDA has changed by +$18.42 M (+17.58%)